Author | Mazyar Shadman, MD, MPH, Fred Hutchinson Cancer Research Center | OncLive

Author | Mazyar Shadman, MD, MPH, Fred Hutchinson Cancer Research Center

Articles

Dr. Shadman on the Efficacy of Venetoclax in CLL

August 20, 2019

Video

Mazyar Shadman, MD, MPH, assistant member, Clinical Research Division, Fred Hutchinson Cancer Research Center, assistant professor, Medical Oncology Division, University of Washington School of Medicine, and attending physician, Hematologic Malignancies, Seattle Cancer Care Alliance, discusses the efficacy of venetoclax (Venclexta) in chronic lymphocytic leukemia (CLL).

Dr. Shadman on the CLL14 Trial in CLL

July 19, 2019

Video

Mazyar Shadman, MD, MPH, assistant member, Clinical Research Division, Fred Hutchinson Cancer Research Center, assistant professor, Medical Oncology Division, University of Washington School of Medicine, and attending physician, Hematologic Malignancies, Seattle Cancer Care Alliance, discusses the phase III CLL14 trial in chronic lymphocytic leukemia (CLL).

Dr. Shadman on Fixed Durations of Treatment in CLL

July 09, 2019

Video

Mazyar Shadman, MD, MPH, assistant member, Clinical Research Division, Fred Hutchinson Cancer Research Center, assistant professor, Medical Oncology Division, Department of Medicine, University of Washington School of Medicine, and attending physician, Seattle Cancer Care Alliance, discusses fixed durations of treatment in chronic lymphocytic leukemia (CLL).

x